Contact this trialFirst, we need to learn more about you.
FDG-PET and Circulating HPV for Cervical Cancer
Recruiting1 award3 criteria
Toronto, Ontario
This trial is testing whether or not plasma HPV DNA can help predict progression or recurrence of cervical cancer after treatment. 20 patients with locally advanced cervical cancer will be recruited.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.